Bleeding complications in patients with out-of-hospital cardiac arrest treated with cangrelor and oral P2Y12 inhibitors
In patients with OHCA undergoing PCI, BARC 3-5 bleeding occurred at a similar rate in patients receiving either cangrelor and transition to an oral P2Y12 inhibitor or an oral P2Y12 inhibitor alone.
Authors
- Christian Zauner (ORCID: https://orcid.org/0000-0002-9585-5903)
- Anselm Jorda (ORCID: https://orcid.org/0000-0001-5500-5878)
- Robert Zilberszac (ORCID: https://orcid.org/0000-0002-8226-6149)
- Jolanta M. Siller‐Matula (ORCID: https://orcid.org/0000-0001-6041-1635)
- Michael Holzer (ORCID: https://orcid.org/0000-0003-3434-703X)
- Thomas Staudinger (ORCID: https://orcid.org/0000-0003-4311-4473)
- Guy Friedrich (ORCID: https://orcid.org/0000-0002-0608-2428)
- Iréne Lang (ORCID: https://orcid.org/0000-0003-0485-2692)
- Georg Gelbenegger (ORCID: https://orcid.org/0000-0003-0995-7178)
- Fabian Plank (ORCID: https://orcid.org/0000-0002-1861-9480)
- Gottfried Heinz
- Bernd Jilma
- Alexandra Julia Lipa
Institutions
- Innsbruck Medical University (AT)
- Universität Innsbruck (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- European Heart Journal Acute Cardiovascular Care
- Published
- 2025-06-06
- DOI
- https://doi.org/10.1093/ehjacc/zuaf082
- Citations
- 3
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 4.16
Funders
- Sanofi